查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1890926

胜任细胞市场：依细胞类型、生物、应用、感受态程度、最终使用者和地区划分

Competent Cells Market, By Cell Type, By Organism Type, By Application, By Competency Level, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年，胜任细胞市值将达到 24.7 亿美元，到 2032 年将达到 48.7 亿美元，2025 年至 2032 年的复合年增长率为 10.2%。

报告内容 报告详情
基准年： 2024 2025年市场规模： 24.7亿美元
历史数据时期： 2020年至2024年 预测期： 2025年至2032年
预测期（2025-2032年）复合年增长率： 10.20% 2032 年的预测值： 48.7亿美元

全球胜任细胞市场在生物技术和製药产业占据重要地位，是分子生物学应用和基因工程过程中不可或缺的基础工具。胜任细胞是指经过化学或物理处理，使其对DNA具有更高渗透性的细菌细胞，使研究人员能够透过转化过程导入外源遗传物质。这些特化的细胞在克隆、蛋白质表现、质体扩增以及各种重组DNA技术中发挥着至关重要的作用，而这些技术正是现代生物技术研发的基础。

该市场涵盖多种胜任细胞，包括胜任细胞感受态细胞和胜任细胞，这些细胞专为从常规克隆到高效转化等特定应用而设计。在基因组学研究的拓展、个人化医疗的进步以及生物技术创新的推动下，全球对可靠和高效的胜任细胞系统的需求持续增长。学术研究机构、製药公司、生物技术公司和受託研究机构（CRO）是主要的终端用户，他们不断需要分子克隆工具和基因工程技术来促进治疗方法开发和科学研究的突破性发现，从而推动了市场成长。

市场动态

全球胜任细胞市场受多种关键驱动因素推动，这些因素正促进其在研究和商业应用领域的扩张。基因体学和蛋白质体学研究投入的不断增长，以及遗传疾病日益增多，亟需创新疗法，是推动市场发展的关键因素。合成生物学方法、CRISPR-Cas9基因编辑技术以及个人化医疗倡议的日益普及，显着提升了对高品质胜任细胞的需求，这些细胞能够进行复杂的基因操作。此外，生物技术产业的扩张，尤其是在新兴经济体，为市场渗透和产生收入创造了巨大的机会。然而，也存在一些显着的限制因素，例如严格的法律法规结构对基因研究和生物技术应用进行监管，这可能导致产品核可延迟，并增加製造商的合规成本。

维持低温运输物流和储存所需的高成本对胜任细胞的科研机构而言构成额外挑战，尤其对于预算有限的小规模科研机构而言更是如此。此外，处理胜任细胞的技术复杂性和专业知识要求也可能限制经验不足的研究人员采用此技术。儘管有这些限制，但药物发现和开发项目的日益普及、将研究活动外包给受託研究机构（CRO）的趋势日益增长，以及胜任细胞在包括生质燃料生产和药品製造在内的工业生物技术过程中的广泛应用，都创造了巨大的机会，并有望推动市场持续增长。

本次调查的主要特点

  • 本报告对全球胜任细胞市场进行了详细分析，以 2024 年为基准年，给出了预测期（2025-2032 年）内的市场规模（十亿美元）和復合年增长率（%）。
  • 它还重点介绍了各个细分市场的潜在商机，并说明了该市场具有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、阻碍因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
  • 本报告根据以下参数对全球胜任细胞市场的主要企业进行了分析：公司概况、产品系列、主要特征、财务绩效和策略。
  • 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 这份全球胜任细胞市场报告的目标受众是该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过全球胜任细胞市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要

第三章 市场动态、监理及趋势分析

  • 市场动态
  • 司机
  • 抑制因素
  • 机会
  • 影响分析
  • 重大进展
  • 法规环境
  • 产品上市及核准
  • PEST分析
  • 波特分析
  • 併购趋势
  • 产业趋势

4. 2020-2032年全球胜任细胞市场（依细胞类型划分）

  • 化学胜任细胞
  • 胜任细胞
  • 超强胜任细胞

5. 2020-2032年全球胜任细胞市场（依生物种类划分）

  • 细菌胜任细胞
  • 酵母胜任细胞
  • 哺乳动物胜任细胞

6. 2020-2032年全球胜任细胞市场依应用领域划分

  • 分子克隆和亚克隆
  • 重组蛋白表达
  • 质体和文库建构（cDNA、基因组、噬菌体、BAC/YAC文库）
  • 突变和定向进化
  • CRISPR/Cas 与基因组编辑工作流程
  • 合成生物学和代谢工程
  • 病毒载体建构与包装支持
  • 其他应用（例如，功能基因体学、路径筛检）

7. 2020-2032年全球能力水准胜任细胞市场

  • 高效胜任细胞
  • 中效胜任细胞
  • 低效率胜任细胞

8. 2020-2032年全球胜任细胞市场（依最终用户划分）

  • 学术和研究机构
  • 生物技术和生物製药公司
  • 合约研究组织（CRO）
  • 诊断与临床研究实验室
  • 工业微生物学和合成生物学公司
  • 政府和非营利研究机构

9. 2020-2032年全球胜任细胞市场

  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 亚太其他地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第十章 竞争格局

  • Thermo Fisher Scientific Inc
  • Merck KGaA Sigma Aldrich
  • Agilent Technologies Inc
  • Takara Bio Inc
  • New England Biolabs Inc
  • Promega Corporation
  • QIAGEN NV
  • Zymo Research Corp
  • Bio Rad Laboratories Inc
  • GenScript Biotech Corporation
  • OriGene Technologies Inc
  • Lucigen brand of LGC Biosearch Technologies
  • HiMedia Laboratories Pvt Ltd
  • Intact Genomics Inc
  • Scarab Genomics LLC

第十一章 分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十二章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8959

Competent Cells Market is estimated to be valued at USD 2.47 Bn in 2025 and is expected to reach USD 4.87 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.47 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 10.20% 2032 Value Projection: USD 4.87 Bn

The global competent cells market represents a critical segment within the biotechnology and pharmaceutical industry, serving as fundamental tools for molecular biology applications and genetic engineering processes. Competent cells are bacterial cells that have been chemically or physically treated to increase their permeability to DNA, enabling researchers to introduce foreign genetic material through transformation procedures. These specialized cells play an indispensable role in cloning, protein expression, plasmid propagation, and various recombinant DNA technologies that form the backbone of modern biotechnology research and development.

The market encompasses various types of competent cells, including chemically competent cells and electrocompetent cells, each designed for specific applications ranging from routine cloning to high-efficiency transformations. With the expanding scope of genomics research, personalized medicine initiatives, and biotechnology innovations, the demand for reliable and efficient competent cell systems continues to surge globally. Academic research institutions, pharmaceutical companies, biotechnology firms, and contract research organizations constitute the primary end users driving market growth through their continuous need for molecular cloning tools and genetic manipulation technologies that facilitate breakthrough discoveries in therapeutic development and scientific research.

Market Dynamics

The global competent cells market is propelled by several key drivers that collectively fuel its expansion across research and commercial applications. The increasing investment in genomics and proteomics research, coupled with the growing prevalence of genetic disorders requiring innovative therapeutic solutions, serves as a primary growth catalyst for market advancement. The rising adoption of synthetic biology approaches, CRISPR-Cas9 gene editing technologies, and personalized medicine initiatives significantly amplifies the demand for high-quality competent cells capable of facilitating complex genetic manipulations. Additionally, the expanding biotechnology sector, particularly in emerging economies, creates substantial opportunities for market penetration and revenue generation. However, the market faces notable restraints including stringent regulatory frameworks governing genetic research and biotechnology applications, which can delay product approvals and increase compliance costs for manufacturers.

The high cost associated with maintaining cold chain logistics and storage requirements for competent cells poses additional challenges, particularly for smaller research institutions with limited budgets. Furthermore, the technical complexity involved in handling competent cells and the requirement for specialized expertise may limit adoption among novice researchers. Despite these constraints, significant opportunities emerge from the increasing focus on drug discovery and development programs, the growing trend of outsourcing research activities to contract research organizations, and the expanding applications of competent cells in industrial biotechnology processes including biofuel production and pharmaceutical manufacturing, positioning the market for sustained growth trajectory.

Key Features of the Study

  • This report provides in-depth analysis of the global competent cells market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global competent cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc, Merck KGaA Sigma Aldrich, Agilent Technologies Inc, Takara Bio Inc, New England Biolabs Inc, Promega Corporation, QIAGEN NV, Zymo Research Corp, Bio Rad Laboratories Inc, GenScript Biotech Corporation, OriGene Technologies Inc, Lucigen brand of LGC Biosearch Technologies, HiMedia Laboratories Pvt Ltd, Intact Genomics Inc, and Scarab Genomics LLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global competent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global competent cells market

Market Segmentation

  • Cell Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Chemically Competent Cells
    • Electrocompetent Cells
    • Ultracompetent Cells
  • Organism Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Bacterial Competent Cells
    • Yeast Competent Cells
    • Mammalian Competent Cells
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Molecular Cloning and Subcloning
    • Recombinant Protein Expression
    • Plasmid and Library Construction (cDNA, genomic, phage, BAC/YAC libraries)
    • Mutagenesis and Directed Evolution
    • CRISPR/Cas and Genome Editing Workflows
    • Synthetic Biology and Metabolic Engineering
    • Viral Vector Construction and Packaging Support
    • Other Applications (e.g., functional genomics, pathway screening)
  • Competency Level Insights (Revenue, USD Bn, 2020 - 2032)
    • High Efficiency Competent Cells
    • Moderate Efficiency Competent Cells
    • Low Efficiency Competent Cells
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Academic and Research Institutes
    • Biotechnology and Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Diagnostic and Clinical Research Laboratories
    • Industrial Microbiology and Synthetic Biology Companies
    • Government and Non-Profit Research Organizations
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific Inc
    • Merck KGaA Sigma Aldrich
    • Agilent Technologies Inc
    • Takara Bio Inc
    • New England Biolabs Inc
    • Promega Corporation
    • QIAGEN NV
    • Zymo Research Corp
    • Bio Rad Laboratories Inc
    • GenScript Biotech Corporation
    • OriGene Technologies Inc
    • Lucigen brand of LGC Biosearch Technologies
    • HiMedia Laboratories Pvt Ltd
    • Intact Genomics Inc
    • Scarab Genomics LLC

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Competent Cells Market, By Cell Type
    • Global Competent Cells Market, By Organism Type
    • Global Competent Cells Market, By Application
    • Global Competent Cells Market, By Competency Level
    • Global Competent Cells Market, By End User
    • Global Competent Cells Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Competent Cells Market, By Cell Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Chemically Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Electrocompetent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ultracompetent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Competent Cells Market, By Organism Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Bacterial Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Yeast Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mammalian Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Competent Cells Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Molecular Cloning and Subcloning
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Recombinant Protein Expression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Plasmid and Library Construction (cDNA, genomic, phage, BAC/YAC libraries)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mutagenesis and Directed Evolution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • CRISPR/Cas and Genome Editing Workflows
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Synthetic Biology and Metabolic Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Viral Vector Construction and Packaging Support
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Applications (e.g., functional genomics, pathway screening)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Competent Cells Market, By Competency Level, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • High Efficiency Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Moderate Efficiency Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Low Efficiency Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Competent Cells Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biotechnology and Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic and Clinical Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Industrial Microbiology and Synthetic Biology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Government and Non-Profit Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Competent Cells Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Thermo Fisher Scientific Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA Sigma Aldrich
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takara Bio Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Promega Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN NV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zymo Research Corp
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio Rad Laboratories Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GenScript Biotech Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • OriGene Technologies Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lucigen brand of LGC Biosearch Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HiMedia Laboratories Pvt Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Intact Genomics Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Scarab Genomics LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us